|
||||||||||||||
|
Quality may be defined as the timely and compliant implementation of regulatory requirements at an optimized cost-benefit ratio. It is difficult to budget quality costs, because partly they are hidden costs which result from under or over compliance. In the domain of optimal compliance the quality costs and the compliance with regulatory requirements are well-balanced (see GxP Compliance).
Compliance risk (non-compliance): In the case of under regulation the quality costs are apparently low, but they may increase significantly in the case of authority complaints or customer reclamation. The consequence can be the loss of confidence and therewith delayed business opportunities or breakdown of business relations. Reasons for underachievment in compliance can be:
Efficiency risk (over-compliance): In the case of over compliance a loss of productivity can be caused if the operating expense for the sustainment of the quality system is too high and consumes a major part of the resources.
It is our objective to lead you to the optimal compliance domain.
|
|||||||||||||
| CMC Pharma GmbH | M5, 8-9 & 11 | D-68161 Mannheim | phone +49-(0)621-400 68 791 | info[at]cmc-pharma.de | Imprint | Contact | © CMC Pharma GmbH 2003 - 2012 | last update: 12.05.2012 |
||||||||||||||
|
||||||||||||||